GPNMB‑Positive Eosinophilic Renal Cell Carcinoma With mTOR‑Pathway Features in a Patient With Germline FLCN Mutation: Diagnostic and Syndromic Implications

2026 ASCP/CAP-ACP Annual Meeting · 19 November 2026 · 12:30–13:15 · 517ABC - Exhibit Hall

GPNMB‑Positive Eosinophilic Renal Cell Carcinoma With mTOR‑Pathway Features in a Patient With Germline FLCN Mutation: Diagnostic and Syndromic Implications was a session at 2026 ASCP/CAP-ACP Annual Meeting on 19 November 2026 in Montreal, with 1 speaker on record.

Speakers

• Thuy Cao — Speaker University of Kansas Medical Center